Expiration date: 08/2025

COMPOSITION: 

One sachet contains:

active substance: glucosamine sulfate sodium chloride equivalent to 100% 

substance 1,884, including glucosamine sulfate 1.5 g

excipients: sorbitol-0,296 g, citric acid 0.02 g.

DESCRIPTION:

White or white with a slightly yellowish powder. Pharmacotherapeutic group: tissue repair stimulator.

PHARMACOLOGICAL PROPERTIES:

Glucosamine sulfate has anti-inflammatory and analgesic effect, whereas deficiency of endogenous glucosamine stimulates the synthesis of proteoglycans and hyaluronic acid of synovial fluid; increases the permeability of the joint capsule and restores enzymatic processes in cells of the synovial membrane and articular cartilage. Contributes to the fixation of sulfur in the synthesis process chondroitinase acid, inhibits the development of degenerative processes in the joints, restores their function, reducing joint pain. 

PHARMACOKINETICS:

Absorption in the GI tract of 90 %, bioavailability of 26 %, the half-life of 70 hours.

INDICATIONS FOR USE:

Osteoarthritis of the peripheral joints, and joints of the spine, osteochondrosis. Contraindications:

Individual hypersensitivity to glucosamine sulfate and other components of the drug. Severe chronic renal failure, pregnancy, lactation.

Is not recommended drug in children (under 12 years) due to the lack of clinical data in this category of patients.

WITH CAUTION:

Intolerance seafood (shrimp, clams), the likelihood of allergic reactions to the drug increases.

Bronchial asthma, diabetes.

METHOD OF APPLICATION AND DOSE:

Inside. The contents of one sachet dissolved in 200 ml of water, taken orally 1 time a day for b weeks.

Doctor's prescription treatment can be repeated with an interval of 2 months. Side effects:

Tolerability is good, in some cases, possible: gastralgia, flatulence, diarrhea, constipation, allergic reactions - hives, itching.

Effects on ability to drive transportation vehicles, mechanisms. Data on the effect on the ability to drive vehicles and operate machinery do not exist.

OVERDOSE:

Cases overdose unknown. Treatment: gastric lavage, symptomatic therapy.

INTERACTION WITH OTHER MEDICINAL PRODUCTS:

Working with non-steroidal anti-inflammatory drugs, paracetamol and corticosteroids. Increases the absorption of Tetra-cyclins, reduces, semisynthetic penicillins, chloramphenicol.

FORM OF ISSUE:

Powder for preparation of solution for oral administration 1.5 g

2,2 g in bags of heat sealable material of the combined "Zelen" brand HC50CA7RT30 documentation of the manufacturer "Sopal", France or "Buflen" on the other 5453-046-45982064-2003.

20 packs together with instructions for use is placed in cardboard pack according to GOST 7933-89 or GOST 123-01-81 or GOST 123-03-80 or OST 64-071-89.

Group packaging and transport packaging in accordance with GOST 17768-90.

STORAGE:

In protected from light place, at temperature not above 25 °C. Keep out of reach of children.

Expiration date: 

2 years. Do not use after expiration date.